The role of apolipoprotein E in Alzheimer’s disease: pharmacogenomic target selection
- 26 July 2000
- journal article
- review article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1502 (1) , 85-94
- https://doi.org/10.1016/s0925-4439(00)00035-1
Abstract
No abstract availableKeywords
This publication has 80 references indexed in Scilit:
- The Apolipoprotein E ε4 Allele and Outcome in Cerebrovascular DiseaseStroke, 1998
- Effect of Apolipoprotein E on Neurite Outgrowth and β‐Amyloid‐Induced Toxicity in Developing Rat Primary Hippocampal CulturesJournal of Neurochemistry, 1997
- Human APOE protein localized in brains of transgenic miceNeuroscience Letters, 1996
- DNA Sequence Recognition by Hybridization to Short Oligomers: Experimental Verification of the Method on theE. coliGenomeGenomics, 1996
- Gene-Representing cDNA Clusters Defined by Hybridization of 57,419 Clones from Infant Brain Libraries with Short Oligonucleotide ProbesGenomics, 1996
- Apolipoprotein E genotypes and Alzheimer's disease in a community study of elderly African AmericansAnnals of Neurology, 1995
- Association of apolipoprotein E4 with sporadic Alzheimer's disease is more pronounced in early onset typeNeuroscience Letters, 1994
- STRUCTURES AND FUNCTIONS OF MULTILIGAND LIPOPROTEIN RECEPTORS: Macrophage Scavenger Receptors and LDL Receptor-Related Protein (LRP)Annual Review of Biochemistry, 1994
- Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease.Proceedings of the National Academy of Sciences, 1993
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993